News
TipRanks on MSN3d
Imunon, Inc. Advances Phase 3 Trial for Innovative Cancer Treatment
Imunon, Inc. (($IMNN)) announced an update on their ongoing clinical study. Imunon, Inc. is conducting a Phase 3 clinical trial titled A ...
Learn about the latest advancements in immunotherapy research focusing on harnessing IL-12 for the treatment of ovarian cancer to potentially improve survival rates.
DelveInsight's,“ Fallopian Tube Cancer Pipeline Insight 2025 ” report provides comprehensive insights about 70+ Fallopian ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback